List of candidates proposed for the election of the Executive Committee of the 17th legislative period
|
|
- Tracy Sanders
- 5 years ago
- Views:
Transcription
1 List of candidates proposed for the election of the Executive Committee of the 17th legislative period Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.v. Gemeinnütziger wissenschaftlicher Verein International Association for Pharmaceutical Technology APV Kurfürstenstraße Mainz/ Executive Committee of the APV ( ) - preliminary list of candidates
2 List of candidates proposed for the election of the Executive Committee Persons Prof. Dr. Johannes Bartholomäus TU Braunschweig and Pharmakreativ Pharmaceutical Development Consulting Burghöhenweg Aachen Prof. Dr. Sandra Klein Institut für Pharmazie Biopharmazie und Pharmazeutische Technologie Ernst-Moritz-Arndt-Universität Greifswald Felix-Hausdorff-Strasse Greifswald Dr. Kathrin Bartscher NextPharma Im Wirrigen Waltrop Dr. Hans Lindner Bayer AG Müllerstrasse Berlin Dr. Karoline Bechtold-Peters Novartis Pharma AG 4002 Basel Werk Klybeck Switzerland Dr. Martin Lück Grünenthal GmbH Zieglerstraße Aachen Prof. Dr. Jörg Breitkreutz Institute of Pharmaceutics and Biopharmaceutics Heinrich-Heine-University Düsseldorf Universitätstr Düsseldorf Prof. Dr. Heribert Häusler Vorm. Boehringer Ingelheim Richard Sorge Straße 73a Berlin Dr. Alexandra Steckel Alfred E. Tiefenbacher GmbH & Co. KG Van-der-Smissen-Strasse Hamburg Dipl.Ing.(TU) Roland Szymoniak Sanofi-Aventis Deutschland GmbH Industriepark Höchst Frankfurt/Main Prof. Dr. Stefan W. Hockertz tpi consult GmbH toxicology-pharmacologyimmunology Ölbergweg Bollschweil,
3 Prof. Dr. Johannes Bartholomäus born 1959 in Lohne i.o. Dr. Kathrin Bartscher born 1978 in Brilon Prof. Dr. Johannes (Hans) Bartholomäus studied Pharmacy ( ) at the TU Braunschweig,, followed by the practical year in the Adler Apotheke, Borken, and Kettelhack Riker Pharma, Borken ( ). He finished his thesis at the Institute of Pharmaceutical Technology of TU Braunschweig under the supervision of Prof. Dr. C. Führer (1988). Hans started his industrial career at Grünenthal GmbH as Head of the Solid Oral Dosage Forms Lab and from 1992 to 2008 he was heading Pharmaceutical Development of Grünenthal. In 2009 Hans started his own Pharmaceutical Development Consultancy. Besides, he is an invited lecturer (since 2001) for Industrial Pharmacy and Honorary Professor (2009) at TU Braunschweig. Currently he is teaching pharmaceutical quality system for Master of Pharmaengineering. His special professional interests are Drug Delivery, Life Cycle Management, IP Management, Quality Systems, Drug Stability, Clinical Supplies and Pharmaceutical Development Strategies including Quality by Design. Hans became member of APV during his Ph.D. studies mid of the 1980ies. He was a co-founding member of APV s Drug Delivery Focus Group in 2003 and became chairman of this group in He was member of the program committees of the 1st European Conference on Pharmaceutics in Reims (2015) and the 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology in Granada (2018). Strengthen internationalization of APV and making APV visible as the European platform for Pharmaceutics, Biopharmaceutics and Pharmaceutical Technologists in Academia, Regulatory Bodies and Industry Grow networking opportunities for members and participants and increase value of APV membership Improve quality of APV processes and standards Prof. Dr. Johannes Bartholomäus TU Braunschweig and Pharmakreativ Pharmaceutical Development Consulting Burghöhenweg Aachen, Dr. Kathrin Bartscher studied Pharmacy at the Westphalian Wilhelms-University of Muenster (). After finishing her doctoral thesis at the Institute for Pharmaceutical Technology and Biopharmaceutics in Muenster under supervision of Prof. Dr. R. Gröning in 2006 she joined NextPharma as formulation scientist. In 2013 she was appointed as Head of Drug Product Development at the NextPharma site in Waltrop she took over the global responsibility for the development activities at all NextPharma sites and joined the NextPharma board in July 2017 as Chief Scientific Officer. She was initiator of the first APV local group in Dortmund. Since 2014 she is member of the APV board and treasurer of APV. Increasing the APV membership value by º º Increasing the opportunities for active contribution to APV activities especially for young colleagues º º Growing APV as platform for scientific exchange Improving the visibility and perception of APV in the market Making the difference with our seminar & conference program by strengthening the international and interdisciplinary focus Re-activating, strengthening and growing the active participation of APV members from pharmaceutical industry Assuring continuity of a stable financial situation as basis for the realization of all our future objectives and visions Dr. Kathrin Bartscher NextPharma Im Wirrigen Waltrop,
4 Dr. Karoline Bechtold-Peters born 1964 in Munich Prof. Dr. Jörg Breitkreutz born 1966 in Marl Dr. Karoline Bechtold-Peters is pharmacist and received her doctorate from the Ludwigs-Maximilians-University of Munich in Pharmaceutical Technology in 1994 for a thesis in the field of enteric-coated pancreatin pellets. In 1994, Karoline started at Boehringer Ingelheim in Ingelheim as Head of Laboratory in Solid Dosage Forms, focusing on powder inhalation therapeutics. In this context, Karoline was instrumental in the development of the blockbuster Spiriva. In 2000, she moved to the Business Unit Biopharmaceuticals of Boehringer Ingelheim and thus to Biberach to build-up Formulation Development of Therapeutic Proteins. In 2003 she was appointed 2003 Head of Global Clinical Supplies, Aseptic Process Development and Process Transfer. After several years in this position, Karoline moved to Basel, Switzerland, in 2011, to join Hoffmann La-Roche and was assigned Head of Drug Product Clinical Supply Center Basel within Global Biologics Europe and was responsible for the production of biopharmaceutical clinical supplies both for Roche and Genentech. It became her core task to ramp up the brand new clinical lines for sterile vials and syringes covering initial inspections and initial batch production from 2011 to The expansion of the production to Antibody- Drug-Conjugates followed. In 2016, Karoline joined Novartis Pharma AG in Basel to focus on more strategic issues of Biopharmaceuticals as Senior Strategy and Technology Leader Pharmaceutics within Biologics Technical Development & Manufacturing. Karoline is member of APV since Besides this she is active in several international organisations such as AAPS, PDA and EBE/EFPIA and is frequently invited to contribute to conferences and papers or books. Ensure that APV is on top of the relevant industry topics Strengthen Biopharmaceuticals within APV Connect APV increasingly to international work streams, further drive the international orientation of APV and strengthen international collaborations Increase the value of APV membership by addressing burning topics Dr. Karoline Bechtold-Peters Novartis Pharma AG 4002 Basel Werk Klybeck, Switzerland Prof. Dr. Jörg Breitkreutz studied Pharmacy ( ) at the Westphalian Wilhelms-University, Münster,. He finished his thesis in 1996 at the Institute for Pharmaceutical Technology and Biopharmaceutics in Münster, under supervision of Prof. Dr. R. Gröning. From 1996 to 1997 he joined Thiemann Arzneimittel GmbH in Waltrop,, as the head of Product Coordination. In 1997 he went back to the university in Münster finishing his habilitation thesis on paediatric drug formulations in Since 2004 he holds a professorship for pharmaceutical technology at the Heinrich-Heine-University in Düsseldorf,. In 2009 he became an APV board member and in 2010 he was elected for president. His research focuses on patient-centric drug development (in particular for children), orphan drugs, process analytical technologies and Green Pharmacy. Jörg Breitkreutz is member of various international societies and networks, Fellow and member of the the Association of American Pharmaceutical Scientists (AAPS). Making APV the home society of all scientists engaged in pharmaceutical technology and industrial pharmacy Binding APV members a whole life long Linking academia and pharmaceutical industry Involvement in public funding programs Strengthening the European leadership of APV Prof. Dr. Jörg Breitkreutz Institute of Pharmaceutics and Biopharmaceutics Heinrich-Heine-University Düsseldorf Universitätstr Düsseldorf,
5 Prof. Dr. Heribert Häusler born 1948 in Saarbrücken Prof. Dr. Stefan W. Hockertz born 1960 in Hannover Prof. Dr. Heribert Häusler studied chemistry at Saarbrücken University and obtained his promotion at the Institute for Analytical Chemistry and Radiochemistry. From1979 to 2013 he worked for Boehringer Ingelheim. There he was Head of the Department Pharmaceutical Production Non Solids until 2002 and was then responsible as Vice President for Department Quality Operations at both sites Biberach and Ingelheim until Up to his retirement in 2013 he acted as a VP in the Corporate Function Quality Systems Excellence. As a honorary professor he got a lectureship for Quality Assurance and Quality Strategy at Mainz University. Since 2017 he has been teaching quality management at Beuth University of Applied Sciences. Prof. Dr. Häusler has also made his mark as an author of scientific publications and EuAB comments. Prof. Dr. Häusler is a member of the APV since Since 2004 he is Vice President of the APV and responsible for the focus groups Analytics/Quality Assurance and Information Technology. To increase cooperations between APV and industrial associations To establish cooperations between pharmaceutical engineers and industrial pharmacists To continue working in the Executive Committee and to contribute to the pofessionalization of APV To further develop the focus groups Analytic and Quality assurance as well as Information Technology Professor Dr. rer. nat. Stefan W. Hockertz is an immunologist and toxicologist, now as CEO of the tpi consult GmbH, one of the European leading toxicological and pharmacological technology consulting companies. Previously, he served as Director and Professor of the Institute of Experimental and Clinical Toxicology at the University Medical School Eppendorf in Hamburg from 2003 to end of Prior to joining the University, he served as Director of the Fraunhofer Institute of Toxicology and Environmental Medicine Hamburg from 1995 to 2002 and before as an investigator at the Fraunhofer Institute of Toxicology and Aerosol Research in Hannover from 1986 to He received his first academic appointment to Hannover University in Prof. Hockertz is appointed as Eurotox Registered Toxicologist and he has the admission as Herstellungsand Kontrolleiter according to 15.1 and 15.3 of the German Drug Law since Hockertz holds a doctorate in biology from the University Hannover and he is a University Professor for Molecular Immunotoxicology of the University Hamburg Medical School. Prof. Hockertz has wide experience as a former board member of a german pharma association. As member of the APV he is working in the Task Force Individual Medicines and he is a guest at the Focus Groups Drug Regulatory Affairs and Drug Delivery. Strengthen the area of preclinical safety and toxicology in the APV. Conditioning the APV for modern and innovative topics like precise medicine and individual medicines. Improving toxicological knowledge of the APV members in drug development, manufacturing, pharmacovigilance and pharmaceutical technology. Increase the number of members by increasing the APV membership value. Prof. Dr. Heribert Häusler Vorm. Boehringer Ingelheim Richard Sorge Straße 73a Berlin, Prof. Dr. Stefan W. Hockertz tpi consult GmbH toxicology-pharmacology-immunology Ölbergweg Bollschweil,
6 Prof. Dr. Sandra Klein born 1970 in Büdingen Dr. Hans Lindner born 1963 in Kiel Prof. Dr. Sandra Klein studied Pharmacy at the University of Frankfurt, and graduated in At the same university she started her graduate studies at the Institute of Pharmaceutical Technology under the supervision of Jennifer Dressman. She got her PhD in 2005 and was then a postdoctoral fellow at Eastman Chemical Company in Kingsport/TN, USA. From 2006 till 2010 Sandra Klein was a senior research associate at the Institute of Pharmaceutical Technology at the University of Frankfurt. Since 2010 she is Professor of Pharmaceutical Technology at the University of Greifswald,. Her current research is focusing on the development of bio-predictive dissolution methods for special patient groups, particularly the pediatric and geriatric population and of patient-centric formulations. Other research interests include the design of predictive and accelerated test methods for vaginal delivery systems and depot parenterals and the enhancement of the bioavailability of poorly soluble drug compunds with different polymer- and cyclodextrin-based approaches. Sandra Klein is an APV member since 2000 and member of the American Association of Pharmaceutical Scientists (AAPS), the Controlled Release Society (CRS) and a core member of the European Paediatric Formulation Initiative (EuPFI) amongst others. Linking APV to the global pharmaceutical network, i.e. strengthening the collaboration of APV with other international societies, universities and industry Further increasing the visibility of APV Improving collaboration of academia and industry Binding young pharmacists to APV giving them the chance to actively participating in activities of the APV network Hans Lindner is a pharmacist and holds a doctorate degree in pharmaceutical technology from Christian-Albrechts- University, Kiel. He started his industrial career at Arzneimittelwerk Dresden in 1994, where he led a scale up team in formulation development. In 1996, he joined Ferring Pharmaceuticals first in, moving later to Denmark. At Ferring, he served in various positions with increasing responsibilities in formulation and pharmaceutical development, at the end overseeing CMC development. He joined Schwarz Pharma in 2004, leading pharmaceutical development. After integration into UCB in 2007, he managed the late stage product development function. In 2008, he joined Bayer, heading pharmaceutical development. In 2012 took responsibility for a newly formed unit overseeing all external activities in pharmaceutical development. Since 2014, he is heading alliance management for research. He leads a global team, developing and running innovative collaboration models with numerous research partners. During his career, Hans has been working with a wide variety of dosage forms, technologies and delivery systems. He has experience in managing functions, technology and knowledge transfers, as well as internal and external interfaces in different organizations. Continue internationalization of APV Support and promote collaboration and network within APV Further Develop and promote APV as valuable organization for its members Prof. Dr. Sandra Klein Institut für Pharmazie Biopharmazie und Pharmazeutische Technologie Ernst-Moritz-Arndt-Universität Greifswald Felix-Hausdorff-Strasse Greifswald, Dr. Hans Lindner Bayer AG Müllerstrasse Berlin,
7 Dr. Martin Lück born 1968 in Rendsburg Dr. Alexandra Steckel born 1982 in St. Petersburg Russia Dr. Martin Lück is Senior Vice President and Head of Drug Development at Grünenthal GmbH, Aachen (). In his current role, he oversees all functions involved in the execution of Grünenthal s Drug Development projects, i.e. Toxicology, Pharmacokinetics & Bioanalytics, CMC, Clinical Operations, Clinical Pharmacology, Biostatistics and Pharmacometrics. He joined Grünenthal in 2010 as Head of Pharmaceutical Development and was appointed Head of CMC in 2014 and Head of Drug Development in From 1998 to 2010 Dr. Lück held various leadership positions in Pharmaceutical Development and Technical Operations at Ferring Pharmaceuticals in, Denmark and Switzerland. Dr. Lück studied Pharmacy at the Christian Albrecht University Kiel. He finished his PhD thesis in Pharmaceutical Technology at the Free University of Berlin under supervision of Prof. Dr. Rainer H. Müller. He received the APV award for the most outstanding doctoral thesis in the pharmaceutical sciences in the year Strengthen interactions between APV and Pharmaceutical Industry Increase visibility of APV in Pharmaceutical Industry to attract new members and keep members actively involved Contribute to APV s seminar and conference programs Dr. Alexandra Steckel studied Pharmacy in St. Petersburg, Russia. She extended the study at Christian Albrecht University of Kiel,, and was awarded the MSc degree of the faculty in She finished her PhD thesis in Pharmaceutical Technology in 2009 at the Institute for pharmaceutical Technology and Biotechnology of the Christian Albrecht University of Kiel under supervision of Prof. Dr. Dr. B. W. Müller. In 2010 she started her industrial career at Losan Pharma GmbH,, as Technology and Business Development Manager where she was responsible for new customer acquisitions for contract development and manufacturing services as well as for licensing business for Losan s generic portfolio. In 2012 Dr. Alexandra Steckel joined Evonik Industies AG,, as Sales Manager for Pharmaceutical Excipients (Eudragit and Resomer ) and Contract Development Services for solid oral and parenteral depot products. In 2015 Dr. Alexandra Steckel joined Alfred E. Tiefenbacher (AET),, as Business Development Manager where she is active upon now. Dr. Steckel is responsible for identification and external development of new products for the generic portfolio of AET. To increase the recognition and visibility of APV as a leading professional and scientific non-profit organization by developing of a new branding and communication strategy for APV with external professionals To support the expansion and internalization of APV Dr. Martin Lück Grünenthal GmbH Zieglerstraße Aachen, Dr. Alexandra Steckel Alfred E. Tiefenbacher (GmbH & Co. KG) Van-der-Smissen-Strasse Hamburg,
8 Dipl. Ing. Roland Szymoniak born 1954 in Mannheim Dipl.Ing.(TU) Roland Szymoniak studied Process Engineering at the Karlsruhe/ University. He started his professional career in 1981 at Hoechst AG and worked for the successor companies Hoechst Marion Roussel GmbH and Aventis Pharma and Sanofi- Aventis first as a plant and process engineer in the active pharmaceutical ingredient production (API) and later as technical and engineering support for all API productions worldwide. After two years of services as an assistant to the Management Board of Hoechst s Pharmaceutical Division and subsequent years of support for both API and manufacturing sites worldwide, he took over responsibility in 1996 as Head of Engineering and Technical Business support at the site Frankfurt Injectables, the largest manufacturing site of Sanofi worldwide. Since January 2010 he assumed worldwide responsibility for his current job as Head of Industrial Engineering & Transfers, both supporting sterile manufacturing sites of Sanofi with global responsibility and being also responsible for all transfer activities of international production transfers into Emerging Markets. From 2010 to 2015 Roland Szymoniak acted as head of the APV focus group Pharmaceutical Process Engineering, which he joined in 1992 and where he still is an active member. Strengthen the industrial/technical aspects in the pharmaceutical APV environment, also introducing inputs from ISPE, the International Society for Pharmaceutical Engineering Support internationalisation of APV and disclosure of benefits of APV seminar participation to Emerging Markets Increase visibility of APV in electronic media and reveal benefits for APV members and not-yet-members Dipl.Ing.(TU) Roland Szymoniak Sanofi-Aventis Deutschland GmbH Industriepark Höchst Frankfurt/Main,
Hot Topic Conference
Hot Topic Conference Biologicals, Medical Devices and Combination Products challenges for packaging materials good practices and new trends 28 to 29 September 2017 Berlin, Germany Course no. 6690 Hot Topics
More informationLife Sciences Queensland announces latest LSQ Ambassadors
MEDIA RELEASE Monday 22 April, 2013 FOR IMMEDIATE RELEASE Life Sciences Queensland announces latest LSQ Ambassadors (LSQ) is pleased to announce our latest LSQ Ambassadors - two of the life sciences industry
More informationLehrkräfte in der CRRA- Ausbildung
Lehrkräfte in der CRRA- Ausbildung Dr. Ferdinand Hund The Program Director of the certificate program in Clinical Research and Regulatory Affairs at the Health Department of the DUW Institut für Weiterbildung
More informationLIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationQuality assurance in the supply chain for pharmaceuticals from the WHO perspective
1 Quality assurance in the supply chain for pharmaceuticals from the WHO perspective Dr Sabine Kopp Quality Assurance and Safety: Medicines Medicines Policy and Standards World Health Organization Presentation
More informationInternational Conference on Pharmaceutical Research and Development June 06-07, 2018 Philadelphia, USA
International Conference on Pharmaceutical Research and Development,, https://research.pharmaceuticalconferences.com Invitation Dear Attendees, We are glad to announce the International Conference on Pharmaceutical
More informationPharmaceutical Process Development
Announcing the following Seminar to be conducted by IVEPE-SEV Pharmaceutical Process Development Factors in Scale-Up, Process Validation and Regulatory Considerations Course Topics Include: Solid Dosage
More informationIgor Fisch. New candidate, independent
Igor Fisch New candidate, independent Igor Fisch is a co-founder of Selexis SA, a biotech company based in Switzerland. He grew the company from inception to profits in less than 5 years with up to > 5MCHF
More informationMember of the Supervisory Board of Linde Aktien gesellschaft since May 2011 as well as member of the Audit Committee and of the Nomination Committee.
PROF. DR OEC. DR IUR. ANN-KRISTIN ACHLEITNER Member of the Supervisory Board of Linde Aktien gesellschaft since May 2011 as well as member of the Audit Committee and of the Nomination Committee. Born 1966
More informationWhere the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes
Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Scientific innovation is at the heart of everything we do. Scientific innovation is at the heart of our business and
More informationManagement Team. Bruce C. Cozadd Chairman and Chief Executive Officer
Bruce C. Cozadd Chairman and Chief Executive Officer Bruce Cozadd joined Jazz Pharmaceuticals at its inception and was appointed Jazz Pharmaceuticals Chief Executive Officer in April 2009. From 2003 until
More informationBy-Elections to the Supervisory Board Information about the proposed candidates:
Information on Item 5 of the Agenda By-Elections to the Supervisory Board Information about the proposed candidates: Franz Fehrenbach, Stuttgart, Chairman of the Board of Management of Robert Bosch GmbH
More informationANNUAL GENERAL MEETING OF SHAREHOLDERS AFFIMED N.V.
ANNUAL GENERAL MEETING OF SHAREHOLDERS AFFIMED N.V. to be held on Tuesday, June 19, 2018 at 15:00 hrs. (CET) at Amsterdam Marriott Hotel, Stadhouderskade 12, 1054 ES Amsterdam, the Netherlands Agenda 1
More informationABRAHAM ABUCHOWSKI, PH.D.
ABRAHAM ABUCHOWSKI, PH.D. Biographical Sketch Dr. Abuchowski is the developer of the current gold standard technology for protein drug delivery called PEGylation. The development of this technology was
More informationSandra E. Peterson appointed new Chairman of the Board of Management of Bayer CropScience
Investor News Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Sandra E. Peterson appointed new Chairman of the Board of Management of Bayer CropScience Current Chairman Prof.
More informationOther appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.
Executive Committee Guido Oelkers Chief Executive Officer Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London,
More informationElection of Members of the Supervisory Board and determination of their remuneration
Magyar Telekom Telecommunications Public Limited Company Submission and resolution proposals to the General Meeting of Magyar Telekom Plc. Subject: Election of Members of the Supervisory Board and determination
More informationpeace of mind For from development to commercial supply
For peace of mind from development to commercial supply aesica-pharma.com weshouldtalk@aesica-pharma.com @aesica CorporateBroEng_v2 0814 @ Aesica 2014 Your full service CDMO Our vision: To be the number
More informationDiscovering The World Of Chemistry
Taros Chemicals GmbH & Co. KG Discovering The World Of Chemistry Chancen zur Beteiligung für kleine und mittlere Unternehmen (KMU) Dr. Dimitrios Tzalis Nationale Informationsveranstaltung zur IMI 2, 10th
More informationPROGRAM OBJECTIVES-M.PHARM (PHARMACEUTICAL ANALYSIS)
PROGRAM OBJECTIVES-M.PHARM (PHARMACEUTICAL ANALYSIS) The Post-Graduates will acquire adequate scientific information regarding basic principles of Pharmaceutics including Cosmetology, Specialized drug
More information18 December University of Oxford Department of Materials Alfred Wong DPhil (Materials) 1993
18 December 2008 University of Oxford Department of Materials Alfred Wong DPhil (Materials) 1993 My history with P&G Began DPhil in Biomaterials Group in September 1990. Attended P&G PhD Seminar in December
More informationPDA 71 Years of Connecting People, Science and Regulation
PDA 71 Years of Connecting People, Science and Regulation 1 I m happy to be here. Bom Dia. Estou feliz por estar aqui. Richard M. Johnson PDA President & CEO since 2009 38 years experience in US and International
More informationMastering Environmental Monitoring
pda.org/eu/em2019 2019 PDA EUROPE TRAINING Mastering Environmental Monitoring 15-16 OCTOBER 2019 WATTWIL, SWITZERLAND CONNECTING PEOPLE SCIENCE AND REGULATION Training & Education Program europe.pda.org
More informationJURY BOARD BUSINESS/INVESTMENT. Pascal BECACHE Founding President, PBS, Healthcare Industry STRATEGY/BUSINESS
Hosted by : Pascal BECACHE Founding President, PBS, Healthcare Industry INNOLABS IDEAS CONTEST 21 st -22 nd June, Paris JURY BOARD BUSINESS/INVESTMENT Pascal is a seasoned executive with GM and Sales VP
More informationtogether innovative global together. innovative. global. GILDEMEISTER Aktiengesellschaft Bielefeld
GILDEMEISTER Aktiengesellschaft Bielefeld isin-code: de0005878003 security code number (wkn): 587800 CVs of the candidates for election into the supervisory board knowledge values power together together.
More informationSection heading. Strapline sub-heading
Section heading Strapline sub-heading Smart every time NextPharma stands out as your pharmaceutical development and manufacturing partner with fast, flexible and tailored solutions for markets worldwide
More informationResearch group self-assessment:
Evaluation of social science research in Norway Research group self-assessment: Research group title: TIK-STS (The Science, Technology and Society group) Research group leader: Kristin Asdal Research group
More informationHealth Care Ltd 3M United Kingdom PLC Every day, 3M people find new ways to make amazing things happen. Wherever they are, whatever they do, the company s customers know they can rely on 3M to help make
More information350 years of historical Milestones
Merck celebrates 350 th anniversary 350 years of historical Milestones 1668: Friedrich Jacob Merck receives a privilege for a pharmacy in Darmstadt Following an apprenticeship at City Hall Pharmacy, Friedrich
More informationTECHNOLOGY, SCIENCE AND CREATIVITY DEVOTED TO CUSTOMER SERVICE
TECHNOLOGY, SCIENCE AND CREATIVITY DEVOTED TO CUSTOMER SERVICE Who we are Our experience, your support. We are one of the leading companies specialized in research, development and manufacturing of pharmaceutical
More informationInclusion Women at the Forefront of STEM
Innovation and Inclusion Women at the Forefront of STEM Hosted by the Association for Women in Science SPONSORSHIP Innovation and Inclusion: Women at the Forefront of STEM The Association for Women in
More informationTranslational scientist competency profile
C-COMEND Competency profile for Translational Scientists C-COMEND is a two-year European training project supported by the Erasmus plus programme, which started on November 1st 2015. The overall objective
More informationICH Q8 / ICH Q11 Training Course
ICH Q8 / ICH Q11 Training Course From QbD to Process Validation Speakers: Dr Thomas Hille LTS Lohmann Therapie- Systeme AG Dr Øyvind Holte Norwegian Medicines Agency, EDQM PAT working party/ EMA PAT team
More informationElections to the Supervisory Board of Siltronic AG
Elections to the Supervisory Board of Siltronic AG Selection Procedure A detailed selection procedure, which is described below, was conducted to prepare the Supervisory Board's resolution proposal for
More informationBayer aligns organization with Life Science businesses
Investor News Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer aligns organization with Life Science businesses Operational management in three divisions: Pharmaceuticals,
More informationAssociate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive
Job Title Alliance Lead Analytics Specialist Associate Director Associate Director Diagnostics Partnering Associate Director Business Development Associate Director Application Architecture Associate Manager
More informationVetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018
Vetter The experts in complex development, aseptic manufacturing and packaging Facts figures data 2018 This is Vetter Founded *50 Sales 2017 Our portfolio Vetter is an international pharmaceutical service
More informationFrom invention to market with PatronUS ip
From invention to market with PatronUS ip From invention to market with PatronUS ip no business should take risks in the field of patent and trade mark law. right from the start, trademarks, inventions,
More informationEUKO 2017 Communication and Digitization
17th interdisciplinary conference of the research network European Cultures in Business and Corporate Communication (EUKO) EUKO 2017 Communication and Digitization 19th 21st October 2017 Frankfurt/Main
More informationScripps Florida. Accelerating Discoveries, Saving Lives. Presentation to the Urban Land Institute November 4, 2011
Scripps Florida Accelerating Discoveries, Saving Lives Presentation to the Urban Land Institute November 4, 2011 Alex Bruner Associate Vice President, Philanthropy 1921- Founding of the Scripps Metabolic
More informationTRAINING COURSE AGENDA
Monday, 25 March 2019 12:00-21:00 12:00 Reception and Welcome Snack 12:30 INTRODUCTION Collection and clustering of the questions contributed by the participants 13:00 THEORY 1 INTRODUCTION TO FREEZE DRYING
More informationAnnual Meeting ISPE Japan Affiliate. Emerging Technology. - Age of Digital and Disruptive Innovation. Dates: 24th & 25th May, 2018
Annual Meeting 2018 ISPE Japan Affiliate Emerging Technology - Age of Digital and Disruptive Innovation Dates: 24th & 25th May, 2018 Place: Host: Tower Hall Funabori (Edogawa-ku, Tokyo) ISPE Japan Affiliate
More informationLabs Network Industrie 4.0 e.v. Konkrete I4.0-Projekte mit KMUs
Labs Network Industrie 4.0 e.v. Konkrete I4.0-Projekte mit KMUs Dr. Dominik Rohrmus July 2017 Plattform Industrie 4.0 in Germany The digital transformation needs a broad-based foundation 2 Plattform Industrie
More informationPurpose of the summary
Summary of Expertise, Experience, and Affiliations and Interests Scientific Advisory Committee on Sciences and Clinical Pharmacology (SAC-PSCP) Purpose of the summary The following table summarizes the
More informationAbout the Authors Blatz Address: Brunke Address: Falckenberg Address: Foerschle
About the Authors Blatz, Michael, has a degree in engineering. Michael Blatz has been providing consulting services to Roland Berger Strategy Consultants clients since 1990, focusing on restructuring and
More informationHerbert K. Haas is a member of the following supervisory boards and comparable control boards outside Germany:
Herbert K. Haas Herbert K. Haas, born in 1954, graduated in business administration in 1980 from the Technical University of Berlin. Mr. Haas spent the early years of his professional career with the Federal
More informationKoen Dejonckheere. Professional experience. Board Memberships. Education
Koen Dejonckheere Professional experience KBC SECURITIES GROUP 2002-2008 Managing Director, responsible for Corporate Finance Previously, Koen Dejonckheere was active in Corporate Finance and Private Equity
More informationINVESTOR PRESENTATION!
INVESTOR PRESENTATION ENHANCING HEALTH THROUGH CANNABIS SCIENCE WWW.EMERALDHEALTH.CA TSX.V:EMH TSX.V:EMH Disclaimer THE STATEMENTS MADE IN THIS PRESENTATION MAY INCLUDE FORWARD-LOOKING STATEMENTS REGARDING
More informationClinical Forum Attendee Sample Job Titles
Account Executive Account Manager Account Manager, New Sales Development - Europe Advisor, Global Medical Channels and ecapabilities Area Sales Director Assistant Director.Assistant Director Pharm. Tr.
More informationIntroduction to STP (Clinical Science) Clinical Pharmaceutical Sciences
Introduction to STP (Clinical Science) Clinical Pharmaceutical Sciences Manchester Pharmacy School 9 Professors 18 Lecturers/Senior Lecturers/Reader 29 Post doc researchers 7 Teaching Fellows/Senior Teaching
More informationPROFILE REPORT. Tenure Track position Optimization for engineering systems
PROFILE REPORT Tenure Track position Optimization for engineering systems Faculty of Science and Engineering, University of Groningen Engineering and Technology Institute Groningen (ENTEG) Profile report:
More informationChemical industry & innovation partnerships: Impact assured!
Dinner Debate in cooperation with CEFIC Chemical industry & innovation partnerships: Impact assured! Hosted by Lieve Wierinck MEP Tuesday, 27 November 2018 19:00 22:00 MEP Salon, European Parliament, Brussels
More informationAssessment of Smart Machines and Manufacturing Competence Centre (SMACC) Scientific Advisory Board Site Visit April 2018.
Assessment of Smart Machines and Manufacturing Competence Centre (SMACC) Scientific Advisory Board Site Visit 25-27 April 2018 Assessment Report 1. Scientific ambition, quality and impact Rating: 3.5 The
More informationHelmut Ernst becomes Chairman of the Board of Directors of ZF Services
Page 1/5, February 25, 2015 Helmut Ernst becomes Chairman of the Board of Directors of ZF Services Industry specialist Ernst embraces connected mobility Telematics services set to open up new business
More informationAdvisory Board. Advisory Board. Advisory Board (1) GMP Manual (Up05) Maas & Peither AG GMP Publishing
(1) Virginia G. Beakes-Read Genentech, USA Ginny works for Genentech, Inc., as the Director, Regulatory Policy Liaison, for the Strategic Operations Office in Washington, D.C. She works on a variety of
More informationDiagnostic assays based on molecular markers Discussion platform on patenting procedures - exchange with NPOs
Diagnostic assays based on molecular markers Discussion platform on patenting procedures - exchange with NPOs Programme Draft 10 11 May 2016 Warsaw, Poland In co-operation with: Venue Patent Office of
More information2012 North American Laboratory Researchers Choice: Future Market Leader of Digital PCR Technology Award
2011 South African Data Centre Green Excellence Award in Technology Innovation Cybernest 2012 2012 North American Laboratory Researchers Choice: Future Market Leader of Digital PCR Technology Award 2011
More informationElections to the Supervisory Board of OSRAM Licht AG
Elections to the of OSRAM Licht AG Nomination Process In preparation for the election of the shareholder representatives to the at the Annual General Meeting of OSRAM Licht AG on February 20, 2018, the
More informationBorn Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016.
Board of Directors Håkan Björklund Chairman Born 1956. Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016. Other appointments: Currently serves as Industry Executive at Avista Capital
More informationIATA Commercial Strategy Symposium 2010 Revenue Management Track Speakers December 9
IATA Commercial Strategy Symposium 2010 Revenue Management Track Speakers December 9 Gary Parker Revenue Management Track Chairman Founder and President, rmexpertise.com With over 22 years working in revenue
More informationTOP INDUSTRY EXPERTS IN ONE TRAINING EVENT!
TOP INDUSTRY EXPERTS IN ONE TRAINING EVENT! Join Natoli and the foremost subject matter experts for a unique hands-on training and troubleshooting panel discussion TONY CARPANZANO FORMULATION STUART PORTER
More informationLIGHTHOUSE. The Science of Pharmaceutical Manufacturing
The Science of Pharmaceutical Manufacturing The Power of headspace inspection insight into the process. On the other hand, rapid non-destructive headspace analysis from is a powerful analytical tool for
More informationAbout the authors Nic Beech Peter Fischer Dieter Frey Marit Gerkhardt John-Philip Hammersen
About the authors Nic Beech is a Professor of Management at the University of St Andrews. His research is focused on the social dynamics of organisational life the intertwining of people s identities,
More informationSection 3 The Desired Human Resource System
Section 3 The Desired Human Resource System 1 Reform of the Human Resource System People are the main actors in promoting science, technology and innovation. One of the most important pillars To strongly
More informationMidwest Regional Forum. Work Smarter Not Harder Leveraging Prior Knowledge to Accelerate CMC Programs
Midwest Regional Forum Work Smarter Not Harder Leveraging Prior Knowledge to Accelerate CMC Programs Tuesday, October 23, 2018 Loews Chicago O Hare Hotel Rosemont, IL Meeting Co-chairs: Sarah Demmon, Eli
More informationTimescales for Change A Look at Innovation in the Pharmaceutical Industry
Timescales for Change A Look at Innovation in the Pharmaceutical Industry 3rd FDA/PQRI Conference on Advancing Product Quality 23 Mar 2017 Robert F. Meyer, Ph.D. Global Pharmaceutical Commercialization
More informationTIME - TABLE Subject & Time: am to pm Sem.- I SEM: - I (NEW) MPC-101 : Modern Pharmaceutical Analytical Techniques
M. PHARM (New) ( w.e.f. July, 2017-2018) Examination May, 2018 NORTH MAHARASHTRA UNIVERSITY, JALGAON Circular No. 163 of 2018 Programme of the Master of Pharmacy (NEW) Examination May, 2018 1. Candidates
More informationJUST SCRATCHING THE SERVICE
CONTRACT MANUFACTURING, PACKAGING & NEW EQUIPMENT TECHNOLOGY FOR THE BIOPHARM/PHARMACEUTICAL INDUSTRY OFFICIAL MEDIA SPONSOR OF W W W. P H A R M P R O. C O M V O L U M E 3 0, N U M B E R 4 M AY 2 0 1 5
More informationSTRATEGY PREFACE
STRATEGY 2018 2022 PREFACE The strategy for WATEC Aarhus University Centre for Water Technology has been conceived, prepared and written in collaboration between the members of WATEC s steering committee
More informationPublication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter
Publication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter Pharma Boardroom An Exclusive Interview with Jonathan Hunt CEO, Syngene International, India. Jonathan Hunt, CEO of Syngene International,
More informationLupin Limited Annual Results FY12. Investor Presentation May being
Lupin Limited Annual Results FY12 Investor Presentation May 2012 Vision: To be an innovation led transnational company Journey over the last decade 5th largest generics player in US Gross Revenues INR
More informationNIHR ROADSHOW FOR MEDTECH SMES
MARTIN HUNT, DIRECTOR FOR INVENTION FOR INNOVATION (i4i) PROGRAMME, NATIONAL INSTITUTE FOR HEALTH RESEARCH Martin is Programme Director for i4i, a translational funding programme. i4i aims to support and
More informationBiotech Concerto #6 Investment Process December 2008
Biotech Concerto #6 Investment Process December 2008 Index Biotech Investment Characteristics Investment Policy Investment Team Scientific Advisory Board Deal Flow Attrition Rate From Screening to Decision
More informationECA. Avoiding Failures & Rejects in Parenteral Manufacturing September 2014, Copenhagen, Denmark. and beyond.
ECA ACADEMY Speakers Martin Dearden UCB Derek Duncan Lighthouse Dr Helmut Gaus Boehringer Ingelheim Al Goodwin Amgen Uli Kuchenbrod Vetter Pharma-Fertigung *New Programme* Image: Seidenader Dr Stephen
More informationSiegfried at a Glance. March 2018
Siegfried at a Glance March 2018 Who are we? Company founded 140 years ago Long-term tradition of pharmaceutics and chemicals Unique selling proposition (USP): development and manufacturing services of
More informationOverview of speakers 12th Stakeholders Day. 4-5 april 2017 helsinki, finland
Overview of speakers 12th Stakeholders Day 4-5 april 2017 helsinki, finland Plenary session 1 Opening Geert Dancet became the first elected Executive Director of the European Chemicals Agency (ECHA) in
More informationDOCUMENTATION. First Interdisciplinary Conference on Technology Transfer, held on 29 and 30 April in Heidelberg, Germany. Co-Organisers and Partners:
DOCUMENTATION First Interdisciplinary Conference on Technology Transfer, held on 29 and 30 April in Heidelberg, Germany Co-Organisers and Partners: 1 Dr Peter Heinrich Chairman of the Board of BIO Deutschland
More informationPROGRAM ANNOUNCEMENT. New Jersey Institute of Technology. MSPhM Systems Engineering. Newark. Fall 2008
PROGRAM ANNOUNCEMENT November 2007 Institution: New Program Title: Degree Designation: Degree Abbreviation: CIP Code and Nomenclature (if possible): Campus(es) where the program will be offered: Date when
More informationHistorical Milestones Our transformation from a pharmacy in 1668 into a global science and technology company
Historical Milestones Our transformation from a pharmacy in 1668 into a global science and technology company 1 of 14 13 Milestones 1668: Friedrich Jacob Merck receives a privilege for a pharmacy in Darmstadt
More informationPROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium
PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data
More informationAPI hapis High Potency Active Pharmaceutical Ingredients. High Potency Active Pharmaceutical Ingredients. Innovation made. Easy.
API hapis High Potency Active Pharmaceutical Ingredients High Potency Active Pharmaceutical Ingredients Innovation made. Easy. 2 High Potency Active Pharmaceutical Ingredients High potency APIs are our
More informationOmeros Raises More Than $63 Million in Financing
Omeros Raises More Than $63 Million in Financing Seattle, WA February 12, 2007 Omeros today announced that it has raised in excess of $63 million in an oversubscribed Series E equity financing. New investors,
More informationResearch Strategy of the TU Ilmenau
Research Strategy of the TU Ilmenau Preamble The TU Ilmenau has a strong position as a research university and is very much committed to fundamental and applied research in specifically identified areas
More informationData-Driven Evaluation: The Key to Developing Successful Pharma Partnerships
R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is
More information10:00 Deriving Process Safety KPIs for the Oil Processing Industry Ernst G. Zirngast, Risk Expert Swiss Reinsurance Company
Program 08:30 Registration 09:00 Opening of SASCON 12 Dr. Peter Müller, Director General of FOCA 09:15 Safety Performance Indicators: Learning from Others? Prof. Dr.-Ing. Wolfgang Kröger ETH Zurich 10:00
More informationA digital health age how to take on the challenges of this advancing field
Page 1 of 7 Custom Search HOME NEWS OPINION TECHNOLOGY ANALYSIS LATEST ISSU 20 September 2017 11:39 A digital health age how to take on the challenges of this advancing field by Norbert Haberland RSS Print
More informationPress release II / 2017 Dresdner scientists print tomorrow s world
Press release II / 2017 Dresdner scientists print tomorrow s world The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden
More informationINVITATION TO THE 2017 EXTRAORDINARY GENERAL MEETING
ZURICH, 31 OCTOBER 2017 TO THE SHAREHOLDERS OF LEONTEQ AG INVITATION TO THE 2017 EXTRAORDINARY GENERAL MEETING Date Venue Wednesday, 22 November 2017 11:00 am (doors open at 10:30 am) Leonteq AG Europaallee
More informationStrategic Plan for CREE Oslo Centre for Research on Environmentally friendly Energy
September 2012 Draft Strategic Plan for CREE Oslo Centre for Research on Environmentally friendly Energy This strategic plan is intended as a long-term management document for CREE. Below we describe the
More information16 th Global Chemicals Think Tank The future of agriculture and food
16 th Global Chemicals Think Tank The future of agriculture and food Basel, 29 th - 30 th of November 2017 Overview Join us for the 16 th Global Chemicals Think Tank Genesis of the Think Tank The Think
More informationSEVENTH TO TWELVETH PRESIDENTS
9. PRESIDENTS 1961. Dr G Dreosti (deceased), Cape Branch 1965. Mr L Ginsburg (deceased), Cape Branch 1972. Mr J de Wit (deceased), Northern Branch 1977. Professor H J H de Muelenaere (deceased), KwaZulu-Natal
More informationDr. Eberhard Bessey. Daimler AG Group Research and Advanced Engineering (GR&AE)
Dr. Eberhard Bessey Daimler AG Group Research and Advanced Engineering (GR&AE) Group Research Product Innovations and Process Technologies - Materials Manufacturing Concepts (GR/PM) Senior Manager Technology
More informationCourse Outline and Syllabus for Students
Course Outline and Syllabus for Students Name: Monica Gautam Course Number: PHM321 Course Title: Selected Topics in Pharmaceutical Industry Course Description: This course is designed to expose students
More informationSupervisory Board of Deutsche Börse Aktiengesellschaft 2018
www.deutsche-boerse.com Election of members of the new Supervisory Board of Deutsche Börse Aktiengesellschaft 2018 Proposal for the election of Supervisory Board members representing the shareholders Proposal
More informationREGISTER EARLY! ADVANCED GMPS AND CURRENT REGULATORY ISSUES WITH FDA AND OTHER REGULATORY AUTHORITIES SPECIAL DISCOUNTS AVAILABLE
A must attend GMP event for all pharmaceutical companies! ADVANCED GMPS AND CURRENT REGULATORY ISSUES WITH FDA AND OTHER REGULATORY AUTHORITIES 11 13 JUNE 2019 COPENHAGEN, DENMARK REGISTER EARLY! SPECIAL
More informationWELCOME AT HTW DRESDEN. Juliane Terpe Introduction HTW Dresden Page 1
WELCOME AT HTW DRESDEN Juliane Terpe Introduction HTW Dresden Page 1 LOCATION OF HTW DRESDEN Kiel Hamburg Schwerin Bremen Berlin Hannover Potsdam Magdeburg Düsseldorf Erfurt Dresden Wiesbaden Mainz Saarbrücken
More informationCrack the Code: Demystify the Success Factors for Career Development
Crack the Code: Demystify the Success Factors for Career Development March 1, 2014, Saturday Rutgers University 675 Hoes Lane West Piscataway, NJ 08854 Sino-American Pharmaceutical Professionals Association
More informationStrategic Management of Innovative Development of the Russian Pharmaceutical Complex
MPRA Munich Personal RePEc Archive Strategic Management of Innovative Development of the Russian Pharmaceutical Complex Natalia Klunko 2013 Online at https://mpra.ub.uni-muenchen.de/54381/ MPRA Paper No.
More informationPATENT ATTORNEYS TRADE MARK ATTORNEYS
PATENT ATTORNEYS TRADE MARK ATTORNEYS 02 INDEPENDENT THINKING. COLLECTIVE EXCELLENCE. Your intellectual property assets are of great value to you. To help you to secure, protect and exploit them, you need
More informationCrossref 2016 Board Election Candidate Statements
Crossref 2016 Board Election Candidate Statements BMJ Representative: Helen King Alternate: Isaac Jones BMJ is a global academic publisher providing a wide range of evidence-based medicine products in
More information